A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma ; volume:9 ; number:1 ; day:20 ; month:5 ; year:2019 ; pages:1-9 ; date:12.2019
Scientific reports ; 9, Heft 1 (20.5.2019), 1-9, 12.2019
- Urheber
-
Wakabayashi, Hiroshi
Inaki, Anri
Yoshimura, Kenichi
Murayama, Toshinori
Imai, Yasuhito
Higuchi, Tetsuya
Jinguji, Megumi
Shiga, Tohru
Kinuya, Seigo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-43880-6
- URN
-
urn:nbn:de:101:1-2019062500334450268179
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wakabayashi, Hiroshi
- Inaki, Anri
- Yoshimura, Kenichi
- Murayama, Toshinori
- Imai, Yasuhito
- Higuchi, Tetsuya
- Jinguji, Megumi
- Shiga, Tohru
- Kinuya, Seigo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients
Publisher Correction: Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
Prognostic values of initial responses to low-dose 131I-MIBG therapy in patients with malignant pheochromocytoma and paraganglioma
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma
Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome
Model systems in SDHx-related pheochromocytoma/paraganglioma
Paraganglioma and pheochromocytoma upon maternal transmission of SDHDmutations
Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma
Evaluating the diagnostic efficacy of whole-body MRI versus 123I-mIBG/131I-mIBG imaging in metastatic pheochromocytoma and paraganglioma
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy
Analysis of SDHAF3 in familial and sporadic pheochromocytoma and paraganglioma
Metabolic implications of hypoxia and pseudohypoxia in pheochromocytoma and paraganglioma
The first Dutch SDHB founder deletion in paraganglioma – pheochromocytoma patients